Nutritional yeast

1. What conditions has Nutritional yeast been studied for?

• Depressive-like behaviors / inflammation-associated mood changes (preclinical): Nutritional yeast supplementation studied in mice in lipopolysaccharide (LPS)-induced and unpredictable chronic mild stress (UCMS)-induced depressive-like behavior models, including interaction with fluoxetine.

• Gut health, immunity, and pathogen shedding (primarily animal agriculture): A review describes yeast derivatives (including streams from nutritional yeast processing) being used to support intestinal health and immunity, improve feed efficiency, and mitigate pathogen shedding in livestock models.

• Probiotic applications / functional fermented foods: Nutritional yeast (Saccharomyces; specifically S. boulardii CNCMI-745 in soy yogurt) studied for probiotic characteristics (stress tolerance, viability) and effects on nutritional composition of soy yogurt.

• Food processing-related “anti-nutritional factors” in legumes (food science): Lentil flours enriched with nutritional yeast studied under extrusion for changes in trypsin inhibitors, lectins, inositol phosphates, and α-galactosides.

• Gluten exposure risk in “gluten-free” contexts (food safety): Nutritional yeast and yeast-containing products tested for gluten proteins; most were below 20 mg/kg, but some samples exceeded this threshold.

• Lactation / milk supply (humans: evidence gap): Brewer’s yeast (related yeast supplement) is used as a galactagogue, but the study explicitly notes no scientifically valid human studies establishing an effect on milk supply; survey data describe perceived benefit.

• Iron deficiency / tolerability of iron supplementation (early-stage): A feasibility trial abstract mentions an iron-yeast complex supplement (FeSC) in physically active females; details/outcomes are not provided in the excerpt.

2. Does it work in treating those conditions? Summarize the evidence.

• Depressive-like behaviors (mice): In the mouse study, nutritional yeast reduced LPS- and UCMS-induced immobility and improved multiple oxido-inflammatory biomarkers (e.g., TNF-α, IL-6, oxidative stress markers) and signaling pathways (CREB/MAPK). Fluoxetine alone was more potent than yeast alone, but the combination (yeast + fluoxetine) produced a more pronounced effect than either treatment alone. This supports potential adjunctive benefit in these animal models, but it is not clinical evidence for depression treatment in humans.

• Gut health/immunity in livestock (review-level evidence): The review describes expanded non-nutritional uses of yeast derivatives (including supporting intestinal health and immunity and reducing pathogen shedding). However, the study is descriptive and does not provide specific trial results, effect sizes, or certainty ratings; it supports plausibility and mechanistic rationale more than definitive efficacy.

• Probiotic/fermented food outcomes (soy yogurt): Using Saccharomyces (nutritional yeast/probiotic yeast) in soy yogurt increased nutritional content more than probiotic lactic acid bacteria in that study, including increases in B vitamins, higher antioxidant activity/phenolic acids, and higher crude protein. This demonstrates functional food enhancement rather than treatment of a disease.

• Lactation (humans): The lactation-focused abstract states: “No scientifically valid studies in humans have been performed that establish any effect of brewer’s yeast on milk supply.” It also notes that ruminant studies suggesting increased milk supply likely reflect improved nutrition (e.g., B vitamins, chromium) rather than a specific lactation mechanism. Survey data show perceived benefit (46% of 190 mothers thought it increased supply), but this is not proof of efficacy.

• Gluten-free safety: Testing shows many nutritional yeast products had gluten below 20 ppm, but at least one nutritional yeast supplement sample exceeded that threshold. This does not address “treatment,” but it does indicate that safety/label suitability is product-dependent.

• Iron deficiency (FeSC): The feasibility trial is mentioned but without results in the provided excerpt, so effectiveness cannot be assessed from these studies.

3. What health benefits does it have?

• Nutrient enrichment in foods: In soy yogurt fermentation, Saccharomyces-containing yogurt showed increases in B vitamins, high crude protein, and higher antioxidant activity and phenolic acids compared with lactic-acid-bacteria yogurt in that study.

• Potential probiotic robustness (strain- and formulation-dependent): S. boulardii CNCMI-745 demonstrated “safety characteristics” and high tolerance to heat, acid, and alkaline stress in the soy yogurt work, and viable counts met commercial yogurt standards.

• Improved nutritional profile via processing (food science): In extruded lentil flour formulations enriched with nutritional yeast, extrusion reduced inositol phosphates and reduced trypsin inhibitor activity and lectins by >90% (beneficial from an anti-nutritional-factor perspective), while increasing α-galactosides (up to 85%), which the authors frame as increasing “desirable prebiotic compounds.”

• Dietary fiber/arabinoxylans changes with extrusion: Another extrusion study found total dietary fiber and arabinoxylans increased after extrusion in lentil flours formulated with nutritional yeasts (though tocopherols decreased and phenolics decreased with higher temperature and higher yeast inclusion).

• Potential immuno-gut functional effects (mainly animal feed context): The yeast-derivatives review highlights bioactive components and proposed mechanisms supporting intestinal health and immunity and serving as alternatives to antibiotic growth promoters in livestock systems (mechanistic/functional positioning rather than direct human clinical outcomes).

• Possible adjunctive neuroimmune effects (preclinical): In mice, yeast supplementation modulated inflammatory and oxidative stress pathways and enhanced fluoxetine’s antidepressant-like effects, suggesting a potential neuroimmune-related benefit that requires human confirmation.

4. Does it have any downsides or side effects?

• Gluten contamination risk (product variability): Although many yeast extracts and nutritional yeast samples tested below 20 mg/kg gluten, one baking yeast and one nutritional yeast supplement sample exceeded the Codex “gluten-free” threshold. For people with celiac disease or strict gluten avoidance, this implies a need for careful product selection and third-party testing/certification when possible.

• Gastrointestinal side effects reported in lactating mothers (brewer’s yeast): The lactation abstract notes “some side effects, mostly gastrointestinal,” reported by nursing mothers taking brewer’s yeast. It also emphasizes wide variation in product content, which can affect tolerability and predictability.

• Processing trade-offs in fortified foods: In extruded lentil flour formulations with nutritional yeast, tocopherol isoforms decreased after extrusion, and total/individual phenolics decreased with higher extrusion temperature and higher yeast inclusion (12–16%). This is not a direct “side effect” of nutritional yeast supplementation per se, but it is a downside relevant to certain processed products that include it.

• Evidence limitations: Several claimed benefits (e.g., lactation support, depression support) are either not supported by valid human trials (lactation) or are based on animal models (depression), so over-reliance for medical purposes is a practical downside.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

No pharmacogenomic findings are provided in the supplied studies. None of the excerpts link nutritional yeast (or yeast derivatives) to outcomes stratified by human genetic variants (e.g., CYP metabolism, transporter polymorphisms, HLA types).

• What can be said from these studies: There is insufficient evidence here to claim benefit or harm for any specific genetic variation.

• Related practical note (not pharmacogenomics): The gluten-testing abstract indicates product-to-product variability in gluten content; this is relevant to gluten-related disorders but is not presented as genotype-specific in these studies.

References

1. Yeast derivatives as a source of bioactive components in animal nutrition: A brief review.
   Rob Patterson, Anna Rogiewicz, Elijah G Kiarie, Bogdan A Slominski (2022) - Frontiers in veterinary science
2. Evaluation of nutritional and physicochemical characteristics of soy yogurt by Lactobacillus plantarum KU985432 and Saccharomyces boulardii CNCMI-745.
   Fathy M Mehaya, Asmaa I El-Shazly, Asmaa Negm El-Dein, Mohamed A Farid (2023) - Scientific reports
3. Novel gluten-free formulations from lentil flours and nutritional yeast: Evaluation of extrusion effect on phytochemicals and non-nutritional factors.
   María Ciudad-Mulero, Virginia Fernández-Ruiz, Carmen Cuadrado, Claudia Arribas, Mercedes M Pedrosa, José De J Berrios, James Pan, Patricia Morales (2020) - Food chemistry
4. Bioactive compounds and antioxidant capacity of extruded snack-type products developed from novel formulations of lentil and nutritional yeast flours.
   María Ciudad-Mulero, Lillian Barros, Ângela Fernandes, José De J Berrios, Montaña Cámara, Patricia Morales, Virginia Fernández-Ruiz, Isabel C F R Ferreira (2018) - Food & function
5. Effect of texturised soy protein and yeast on the instrumental and sensory quality of hybrid beef meatballs.
   Simona Grasso, Gabrielle Smith, Sophie Bowers, Oluseyi Moses Ajayi, Mark Swainson (2019) - Journal of food science and technology
6. Porcine intestinal yeast species, Kazachstania slooffiae, a new potential protein source with favourable amino acid composition for animals.
   V Urubschurov, K Büsing, W-B Souffrant, N Schauer, A Zeyner (2018) - Journal of animal physiology and animal nutrition
7. Saccharomyces cerevisiae Yeast-Based Supplementation as a Galactagogue in Breastfeeding Women? A Review of Evidence from Animal and Human Studies.
   Lili Lily Jia, Louise Brough, Janet Louise Weber (2021) - Nutrients
8. Analysis of Gluten in Dried Yeast and Yeast-Containing Products.
   Laura K Allred, Mitchell G Nye-Wood, Michelle L Colgrave (2020) - Foods (Basel, Switzerland)
9. Effect of Different Wheat-Based Diets and Corn Meal Addition on Development Parameters of Ephestia kuehniella (Zeller, 1879) (Lepidoptera: Pyralidae).
   L M Parra, A G Garcia, G R Alves, S R Magro, J R P Parra (2022) - Journal of insect science (Online)
10. Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.
    Augustina Potokiri, Noah A Omeiza, Abayomi M Ajayi, Paul A Adeleke, Abdullateef I Alagbonsi, Ezekiel O Iwalewa (2024) - Current research in physiology
11. Encapsulation of Saccharomyces spp. for Use as Probiotic in Food and Feed: Systematic Review and Meta-analysis.
    Isabel Marie Grambusch, Caroline Schmitz, Cláudia Schlabitz, Rodrigo Gay Ducati, Daniel Neutzling Lehn, Claucia Fernanda Volken de Souza (2024) - Probiotics and antimicrobial proteins
12. Brewer's Yeast
13. Exploring tolerance and side effects of an innovative yeast-bound iron supplement: a feasibility trial.
    Keely A Shaw, Thomas A Tompkins, Brendan Abrahamson-Durant, Gillian MacNevin, Jill A Parnell, Martin J MacInnis, Raylene A Reimer, Jane Shearer (2025) - Pilot and feasibility studies
14. Natural Language Processing and Machine Learning Techniques for Analyzing Conversations About Nutritional Yeasts in the United States and France: Retrospective Social Media Listening Study.
    Jean-François Jeanne, Joelle Malaab, Antoine Vanhove, Florian Mourey, Manissa Talmatkadi, Stéphane Schück (2025) - JMIR infodemiology

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.